HighTower Advisors
ZBH icon

HighTower Advisors’s Zimmer Biomet ZBH Stock Holding History

HighTower Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-309
Closed -$1K – 2439
2018
Q2 		$1K Buy
+309
New +$33.6K ﹤0.01% 2229

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's ZBH Position: Q1 2026 in Review

HighTower Advisors increased its Zimmer Biomet (ZBH) stake by 16% in Q1 2026, buying an estimated $259K and bringing the position to 20,674 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

HighTower Advisors first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $20.8M in Q1 2024. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • HighTower Advisors held 20,674 shares of Zimmer Biomet worth $1.87M as of Q1 2026.
  • HighTower Advisors bought 2,824 Zimmer Biomet shares in Q1 2026, an estimated $259K.
  • Zimmer Biomet made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1757 holding.
  • HighTower Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
  • HighTower Advisors's Zimmer Biomet position peaked at $20.8M in Q1 2024.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.